Silence Therapeutics (SLN) Capital Expenditures (2024 - 2025)
Silence Therapeutics' (SLN) quarterly Capital Expenditures came in at $3000.0 in Q3 2025, down 95.31% year-on-year from $64000.0 in Q3 2024, and down 93.75% quarter-over-quarter from $48000.0 in Q2 2025.
Silence Therapeutics (SLN) Capital Expenditures (2024 - 2025) Analysis & Trends
Silence Therapeutics has disclosed Capital Expenditures across 2 years of filings, most recently posting $3000.0 for Q3 2025.
- Capital Expenditures for Q3 2025 came in at $3000.0, down 95.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $51000.0 (down 76.28% YoY), and the FY2025 annual result was $55000.0, down 73.93% from the prior year.
- Capital Expenditures came in at $3000.0 for Q3 2025 at Silence Therapeutics, down from $48000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $85000.0 in Q2 2024 to a low of $3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Silence Therapeutics | 966.41 Mn | 896.33 Mn | 411,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 85,000.00 |
| Jun 30, 2024 | 85,000.00 |